Showing results (251-260 of 263) with videos related to

Sort By:
Pageof 27
European Journal of Immunology|August 1, 1993
Enhancing effect of natural killer cell stimulatory factor (NKSF/interleukin-12) on cell-mediated cytotoxicity against tumor-derived and virus-infected cellsJ Chehimi, N M Valiante, A D'Andrea, et al.
The Journal of Infectious Diseases|November 9, 2000
Patterns of plasma human immunodeficiency virus type 1 RNA response to highly active antiretroviral therapy in infected childrenS A Spector, K Hsia, F H Yong, et al.
Archives of Pediatrics & Adolescent Medicine|April 18, 2000
T-lymphocyte subsets in HIV-infected and high-risk HIV-uninfected adolescents: retention of naive T lymphocytes in HIV-infected adolescents. The Adolescent Medicine HIV/AIDS Research NetworkS D Douglas, B Rudy, L Muenz, et al.
The Journal of Infectious Diseases|February 1, 1997
Sequential and combined use of inactivated and oral poliovirus vaccines: Dolj District, Romania, 1992-1994N Ion-Nedelcu, P M Strebel, F Toma, et al.
Virology|January 1, 1994
Induction of rotavirus-specific cytotoxic T lymphocytes by vaccinia virus recombinants expressing individual rotavirus genesP A Offit, B E Coupar, Y M Svoboda, et al.
The Journal of Pediatrics|August 1, 1991
Comparison of acellular and whole-cell pertussis-component diphtheria-tetanus-pertussis vaccines in infants. The APDT Vaccine Study GroupD A Blumberg, C M Mink, J D Cherry, et al.
Annals of Internal Medicine|October 1, 1984
Comparative virulence and immunogenicity of the Towne strain and a nonattenuated strain of cytomegalovirusG V Quinnan, M Delery, A H Rook, et al.
Archives of Surgery (Chicago, Ill. : 1960)|December 1, 1988
Prophylaxis of serious cytomegalovirus infection in renal transplant candidates using live human cytomegalovirus vaccine. Interim results of a randomized controlled trialK L Brayman, D C Dafoe, W R Smythe, et al.
The Journal of Infectious Diseases|December 1, 1996
Application of the polymerase chain reaction to the diagnosis and management of neonatal herpes simplex virus disease. National Institute of Allergy and Infectious Diseases Collaborative Antiviral Study GroupD W Kimberlin, F D Lakeman, A M Arvin, et al.
The Journal of Infectious Diseases|August 7, 1999
A canarypox vector expressing cytomegalovirus (CMV) glycoprotein B primes for antibody responses to a live attenuated CMV vaccine (Towne)S P Adler, S A Plotkin, E Gonczol, et al.
Pageof 27